The expression of GLUT1 and GLUT6 increased, while GLUT4 and SREBP2 decreased in glioma cell lines, confirming the gene expression patterns observed in the tumor tissues (Fig. 1g). The gene discussed is SLC2A4; the disease is central nervous system cancer.